한글목차

세계의 벤더 뉴트럴 아카이브(VNA) 및 PACS(의료영상저장전송시스템) 시장 규모는 2024년 46억 달러에서 2029년에는 73억 달러에 달하며, 2024-2029년의 CAGR은 9.5%에 달할 것으로 예측됩니다.

이 시장의 성장을 지원하고 있는 것은 의료 기록 및 의료 영상 데이터의 급속한 디지털화, 법규제에 대한 대응, 데이터 보존·관리 솔루션에 대한 요구의 증가입니다. 그러나 기존 헬스케어 IT 시스템과의 통합, 데이터 보안과 프라이버시에 관한 우려가 이 시장에서 큰 과제가 되고 있습니다.

제품 유형별로는 벤더 뉴트럴 아카이브(VNA) 및 PACS(의료영상저장전송시스템) 시장은 VNA와 PACS(의료영상저장전송시스템)으로 구분됩니다. VNA 부문은 2023년에 최대 시장 점유율을 차지했습니다. VNA 부문에는 부문 VNA, 복수 부문 VNA, 복수 사이트 VNA가 포함됩니다. 예측 기간 중 멀티 사이트 VNA 부문이 가장 높은 성장을 나타냅니다. 이 부문의 성장에 기여하는 주요 요인의 하나는 헬스케어 시스템내에서 심리스 데이터 접근성과 상호운용성에 대한 수요의 증가입니다. 의료기관이 업무의 효율화와 환자 케어의 향상에 노력하는 가운데 복수 시설 및 이종 시스템의 의료용 영상 데이터를 단일 집중 리포지토리에 통합하기 위해 VNA를 이용하는 케이스가 증가하고 있습니다. 이것에 의해 헬스케어 프로바이더는 장소에 관계없이 환자 정보에 효율적으로 액세스할 수 있게 되며, 진단 정도와 치료 계획의 향상으로 연결됩니다. 또한 또한 COVID-19 팬데믹으로 인해 원격의료와 원격 환자 모니터링의 도입이 가속화되면서 다기관 VNA에 대한 수요가 더욱 증가하고 있습니다. 의료 서비스 프로바이더는 가상 진료 및 원격 진단을 위해 의료 영상 데이터에 대한 원격 액세스를 점점 더 많이 사용하고 있으며, 중앙 집중식, 안전하고 상호 운용 가능한 스토리지 솔루션의 필요성이 더욱 분명해지고 있습니다.

벤더 뉴트럴 아카이브 및 PACS 시장은 도입 형태에 따라 온프레미스 모델과 클라우드 기반 모델로 구분되며, 2023년에는 온프레미스 모델이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 온프레미스 솔루션과 관련된 비용 구조로 인해 특히 예산 제약이 있는 의료기관이나 운영 비용보다 자본 지출을 우선시하는 의료기관에서 온프레미스 솔루션이 많이 활용되고 있기 때문입니다. 또한 의료기관이 도입 모델을 선택할 때 총소유비용(TCO)은 여전히 중요한 고려사항입니다. 클라우드 기반 VNA는 초기 비용 절감과 확장성 등의 장점이 있지만, 특히 스토리지 요구사항이 예측 가능하고 IT 인프라가 잘 구축된 조직에서는 온프레미스 도입이 장기적으로 더 비용 효율적일 수 있습니다. 스토리지 기술과 보다 효율적인 하드웨어 옵션의 발전으로 온프레미스 VNA는 클라우드 기반 대안에 비해 낮은 총소유비용(TCO)으로 더 높은 성능과 안정성을 제공할 수 있습니다. 그러나 예측 기간 중 CAGR은 클라우드 기반 모델이 가장 빠른 것으로 나타났습니다.

세계의 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장에 대해 조사했으며, 모달리티별, 도입 형태별, 제품 유형별, 벤더 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 서론
• 시장 역학

제6장 업계의 동향

• 현재의 동향
• 기술 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 밸류체인 분석
• 에코시스템 매핑
• Porter's Five Forces 분석
• 주요 컨퍼런스와 이벤트
• 가격 분석
• 규제 상황
• 특허 분석
• 사례 연구 분석
• 주요 이해관계자와 구입 기준
• 최종사용자 분석
• 벤더 뉴트럴 아카이브(VNA) 및 PACS(의료영상저장전송시스템) 시장 : 비즈니스 모델

제7장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(모달리티별)

• 서론
• CT
• 맘모그래피
• 초음파
• 자기공명영상법(MRI)
• X선
• PET

제8장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(도입 형태별)

• 서론
• 온프레미스 모델
• 클라우드 기반 모델
• 하이브리드 모델

제9장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(제품 유형별)

• 서론
• VNA
• PACS

제10장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(벤더 유형별)

• 서론
• 독립 벤더
• 서드파티 벤더

제11장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(용도별)

• 서론
• 심장병과
• 정형외과
• 종양과
• 신경과
• 산부인과
• 기타

제12장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(최종사용자별)

• 서론
• 병원과 클리닉
• 진단 센터
• 외래 수술 센터
• 기타

제13장 벤더 뉴트럴 아카이브 및 PACS(의료영상저장전송시스템) 시장(지역별)

• 서론
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제14장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/비책
• 주요 기업의 매출 점유율 분석
• 시장 점유율 분석
• 브랜드/소프트웨어 비교 분석
• 기업 평가와 재무 지표
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 경쟁 상황과 동향

제15장 기업 개요

• 주요 참여 기업
  • AGFA-GEVAERT GROUP
  • FUJIFILM HOLDINGS CORPORATION
  • SECTRA AB
  • GE HEALTHCARE TECHNOLOGIES INC.
  • MERATIVE
  • KONINKLIJKE PHILIPS N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • INTELERAD MEDICAL SYSTEMS INCORPORATED
  • PAXERAHEALTH
  • NOVARAD CORPORATION
  • HYLAND SOFTWARE, INC.
  • SIEMENS HEALTHCARE LIMITED
  • BRIDGEHEAD SOFTWARE LTD.
  • CANOPY PARTNERS
  • CRELIOHEALTH INC.
  • ASPYRA, LLC
  • POSTDICOM
  • MEDICASOFT
  • ESAOTE SPA
  • VISUS HEALTH IT GMBH
• 기타 기업
  • ADVAHEALTH SOLUTIONS
  • SOFTTEAM SOLUTIONS PVT. LTD.
  • ARO SYSTEMS
  • CENTRAL DATA NETWORKS
  • ONEPACS
  • DEDALUS S.P.A.

제16장 부록

영문목차

The global Vendor Neutral Archive ( VNA ) & PACS market is projected to reach USD 7.3 billion by 2029 from USD 4.6 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. The growth of the market is fuelled by rapid digitization of healthcare records and medical imaging data, regulatory compliance requirements, and growing need for data storage and management solutions. However, integration with existing healthcare IT system, data security and privacy concerns poses a significant challenge within this market.

"Vendor Neutral Archive ( VNA ) & PACS, multi-site VNA segment to witness the highest growth during the forecast period."

Based on product type, the Vendor Neutral Archive ( VNA ) & PACS market is segmented into VNA and PACS. The VNA segment held the largest market share in 2023. The VNA segment encompasses of department VNA, multi-department VNA and multi-site VNA. The multi-site VNA segment to witness the highest growth during forecast period. One major factor contributing to the growth of this segment is the increasing demand for seamless data accessibility and interoperability within healthcare systems. As healthcare organizations strive to streamline their operations and improve patient care, they are increasingly turning VNAs to consolidate medical imaging data from multiple sites and disparate systems into a single, centralized repository. This enables healthcare providers to access patient information efficiently, regardless of location, leading to enhanced diagnostic accuracy and treatment planning. Moreover, the COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring, further driving the demand for multi-site VNAs. With healthcare providers increasingly relying on remote access to medical imaging data for virtual consultations and remote diagnostics, the need for a centralized, secure, and interoperable storage solution has become more distinct ultimately driving the growth of this segment throughout the forecast period.

"On-premise model held the largest market share in the Vendor Neutral Archive ( VNA ) & PACS Market ."

Based on deployment, the Vendor Neutral Archive ( VNA ) & PACS market is segmented into on-premise and cloud based model. The on-premise mode of deployment held the largest market share in 2023. As the cost structure associated with on-premise solutions are used by several healthcare organizations, especially those with budget constraints or a preference for capital expenditures over operational expenses. Furthermore, the total cost of ownership (TCO) remains a significant consideration for healthcare organizations when choosing between deployment models. While cloud-based VNAs offer advantages such as lower upfront costs and scalability, on-premises deployments can be more cost-effective over the long term, especially for organizations with predictable storage needs and established IT infrastructures. With advancements in storage technologies and more efficient hardware options, on-premises VNAs can deliver high performance and reliability at a lower TCO compared to cloud-based alternatives. However, cloud-based model will grow at the fastest CAGR in the forecast period.

" Hospital & Clinics segment to register the highest growth in the Vendor Neutral Archive ( VNA ) & PACS market during the forecast period."

Based on end user, the Vendor Neutral Archive ( VNA ) & PACS solution market is segmented into hospitals and clinics, ambulatory surgical centers, long-term care facilities, nursing centers and other end-users which includes maternity care centers, trauma & emergency care centers. In 2023, the hospital & clinics segment held the largest share among the end users. As these end-user are witnessing a growing volume of medical imaging data generated from various diagnostic modalities such as X-rays, MRIs, CT scans, and ultrasounds. This surge in imaging data is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical imaging technology. As hospitals and clinics continue to prioritize efficiency, collaboration, and compliance, VNA and PACS solutions will play a crucial role in transforming healthcare delivery and enhancing patient outcomes.

"APAC is estimated to register the highest CAGR during the forecast period."

In this report, the Vendor Neutral Archive ( VNA ) & PACS market is segmented segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Vendor Neutral Archive ( VNA ) & PACS market in APAC is projected to register the highest CAGR rate during the forecast period. The growth of this region is due to rising medical imaging investments, and technological advancements in diagnostic imaging modalities. Moreover, advancements in technology and the growing prevalence of cloud computing are making VNA and PACS more accessible and affordable in APAC region. As healthcare providers in APAC continue to prioritize efficiency, accessibility, and quality of care, VNA and PACS solutions will play a pivotal role in driving healthcare transformation and improving patient outcomes across the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: C-level (35%), Director-level (45%), and Others (20%)
• By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%) and Middle East Africa (5%)

List of Companies Profiled in the Report

• Hyland Software, Inc. (US)
• Agfa-Gevaert Group. (Belgium)
• Intelerad Medical Systems Inc (Canada)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• FUJIFILM Holdings Corporation (Japan)
• GE HEALTHCARE TECHNOLOGIES INC. (US),
• Merative (US)
• Sectra AB (Sweden)
• Siemens Healthcare Limited (Germany)
• BridgeHead Software Ltd. (UK)
• Canopy Partners. (US)
• Novarad Corporation.(US)
• POSTDICOM (Netherlands)
• AdvaHealth Solutions Pte Ltd (Singapore)
• CrelioHealth (India)
• Medicasoft. (US)
• Esaote SPA (Italy)
• PaxeraHealth (US)
• VISUS Health IT GmbH (Germany)
• S (US), Dedalus S.p.A. (Italy)
• SoftTeam Solutions Pvt Ltd. (India)
• ARO Systems (Australia)
• Central Data Networks (Australia)
• ONEPACS (US)

Research Coverage

This report studies the Vendor Neutral Archive ( VNA ) & PACS market based on product type, modality, deployment, vendor type, application, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Vendor Neutral Archive ( VNA ) & PACS market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (growing volume of medical Imaging data, shift towards value-based care and digital transformation, healthcare IT-specific government regulations), restrains (rising incidences of data breaches, interoperability challenges), challenges (lack of standardization, user adoption and training), opportunities (patient-centric approach to deliver enhanced care to open new avenues for development of VNAs, cloud-based solutions to represent high-growth opportunites) are contributing the growth of the Vendor Neutral Archive ( VNA ) & PACS market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Vendor Neutral Archive ( VNA ) & PACS market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, application, end-user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Vendor Neutral Archive ( VNA ) & PACS market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Vendor Neutral Archive ( VNA ) & PACS Market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
• 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
• 2.2 RESEARCH METHODOLOGY DESIGN
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• 2.3 MARKET SIZE ESTIMATION
  • FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  • 2.3.1 BOTTOM-UP APPROACH
  • FIGURE 6 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BOTTOM-UP APPROACH
  • 2.3.2 TOP-DOWN APPROACH
  • FIGURE 7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: TOP-DOWN APPROACH
  • 2.3.3 TOP-DOWN APPROACH FOR PARENT MARKET ASSESSMENT
  • 2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • TABLE 1 FACTOR ANALYSIS
  • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 OVERALL STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS
• 2.8 RECESSION IMPACT ANALYSIS
  • TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)
  • TABLE 3 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 4 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 11 VNA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 12 CT SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029
• FIGURE 13 CLOUD-BASED MODEL SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
• FIGURE 14 INDEPENDENT VENDOR SEGMENT TO ACCOUNT FOR LARGER SHARE BY 2029
• FIGURE 15 CARDIOLOGY SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
• FIGURE 16 HOSPITALS & CLINICS SEGMENT TO LEAD MARKET IN 2024
• FIGURE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 OVERVIEW OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • FIGURE 18 INCREASING VOLUME OF MEDICAL IMAGING DATA TO DRIVE MARKET
• 4.2 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE AND COUNTRY
  • FIGURE 19 VNA SEGMENT AND JAPAN TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
• 4.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL MIX
  • FIGURE 21 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
• 4.5 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEVELOPED VS. EMERGING MARKETS
  • FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 23 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Heightened investments in medical imaging technologies
    • 5.2.1.2 Growing demand for streamlined healthcare data management solutions
    • 5.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs)
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial investment
    • 5.2.2.2 Lack of standardized protocols and interoperability frameworks
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Government initiatives to increase penetration of Al in medical imaging
    • 5.2.3.2 Increasing medical imaging procedures and large imaging data silos
    • 5.2.3.3 Rapid uptake of big data in healthcare
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Rising security concerns related to cloud-based image processing and analytics
    • 5.2.4.2 Data security issues

6 INDUSTRY TRENDS

• 6.1 CURRENT TRENDS
  • 6.1.1 CLOUD ADOPTION
  • 6.1.2 AI INTEGRATION
  • 6.1.3 VALUE-BASED CARE FOCUS
• 6.2 TECHNOLOGY ANALYSIS
  • 6.2.1 KEY TECHNOLOGIES
    • 6.2.1.1 DICOM (Digital Imaging and Communications in Medicine)
    • 6.2.1.2 Enterprise imaging solutions
    • 6.2.1.3 Cloud-based storage and services
  • 6.2.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.2.1 Image exchange networks
    • 6.2.2.2 Data analytics and business intelligence
  • 6.2.3 ADJACENT TECHNOLOGIES
    • 6.2.3.1 Health Information Exchange (HIE)
• 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 24 REVENUE SHIFT IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
• 6.4 VALUE CHAIN ANALYSIS
  • FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS
• 6.5 ECOSYSTEM MAPPING
  • FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING
• 6.6 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 IMPACT OF PORTER'S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • 6.6.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.6.2 BARGAINING POWER OF SUPPLIERS
  • 6.6.3 BARGAINING POWER OF BUYERS
  • 6.6.4 THREAT OF NEW ENTRANTS
  • 6.6.5 THREAT OF SUBSTITUTES
• 6.7 KEY CONFERENCES & EVENTS
  • TABLE 6 LIST OF CONFERENCES & EVENTS, 2024-2025
• 6.8 PRICING ANALYSIS
  • 6.8.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
  • TABLE 7 AVERAGE SELLING PRICE OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
  • 6.8.2 AVERAGE SELLING PRICE TREND, BY REGION
• 6.9 REGULATORY LANDSCAPE
  • 6.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.9.2 REGULATIONS
    • 6.9.2.1 US
    • 6.9.2.2 Europe
    • 6.9.2.3 China
    • 6.9.2.4 Japan
    • 6.9.2.5 India
• 6.10 PATENT ANALYSIS
  • 6.10.1 PATENT PUBLICATION TRENDS FOR VNA AND PACS
  • FIGURE 27 GLOBAL PATENT PUBLICATION TRENDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2015-2024
  • 6.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS (JANUARY 2015 TO APRIL 2024)
• 6.11 CASE STUDY ANALYSIS
  • 6.11.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM
  • 6.11.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
  • 6.12.2 BUYING CRITERIA
  • FIGURE 30 KEY BUYING CRITERIA FOR TOP END USERS
  • TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
• 6.13 END-USER ANALYSIS
  • 6.13.1 UNMET NEEDS
  • TABLE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: UNMET NEEDS
  • 6.13.2 END-USER EXPECTATIONS
  • TABLE 15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END-USER EXPECTATIONS
• 6.14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BUSINESS MODELS
  • 6.14.1 ENTERPRISE LICENSING:
  • 6.14.2 SOFTWARE-AS-A-SERVICE (SAAS):
  • 6.14.3 PAY-PER-USE:
  • 6.14.4 HYBRID MODELS:

7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY

• 7.1 INTRODUCTION
  • TABLE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• 7.2 CT
  • 7.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH
  • TABLE 18 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 19 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 7.3 MAMMOGRAPHY
  • 7.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
  • TABLE 20 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 21 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 7.4 ULTRASOUND
  • 7.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH
  • TABLE 22 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 23 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 7.5 MAGNETIC RESONANCE IMAGING (MRI)
  • 7.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET
  • TABLE 24 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 25 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 7.6 X-RAY
  • 7.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET
  • TABLE 26 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 27 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 7.7 PET
  • 7.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET
  • TABLE 28 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 29 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

8 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL

• 8.1 INTRODUCTION
  • TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• 8.2 ON-PREMISES MODEL
  • 8.2.1 ON-PREMISES DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA
  • TABLE 32 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 33 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 8.3 CLOUD-BASED MODEL
  • 8.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL'S POPULARITY
  • TABLE 34 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 35 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 8.4 HYBRID MODEL
  • 8.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS
  • TABLE 36 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 37 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE

• 9.1 INTRODUCTION
  • TABLE 38 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• 9.2 VNA
  • TABLE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 41 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.2.1 DEPARTMENT VNA
    • 9.2.1.1 Limitations in addressing scalability and interoperability challenges across diverse departments to hinder market growth
  • TABLE 44 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 45 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.2.2 MULTI-DEPARTMENT VNA
    • 9.2.2.1 Trend toward adopting value-based platform solutions to support market growth
  • TABLE 46 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 47 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.2.3 MULTI-SITE VNA
    • 9.2.3.1 Need for storage of large medical image data and seamless sharing within and between enterprises to support market growth
  • TABLE 48 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 49 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 9.3 PACS
  • TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.3.1 DEPARTMENT PACS
    • 9.3.1.1 Increasing storage of medical imaging data across various applications to support market growth
  • TABLE 54 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 55 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.3.2 MULTI-DEPARTMENT PACS
    • 9.3.2.1 Streamlining radiology operations for enhanced image accessibility to support market growth
  • TABLE 56 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 57 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • 9.3.3 MULTI-SITE PACS
    • 9.3.3.1 Advancement in cloud-based PACS solutions to propel market growth
  • TABLE 58 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 59 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE

• 10.1 INTRODUCTION
  • TABLE 60 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 61 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• 10.2 INDEPENDENT VENDOR
  • 10.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE
  • TABLE 62 INDEPENDENT VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • TABLE 63 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 64 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 10.3 THIRD-PARTY VENDOR
  • 10.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS' PRESENCE IN MARKET
  • TABLE 65 THIRD-PARTY VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  • TABLE 66 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 67 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION

• 11.1 INTRODUCTION
  • TABLE 68 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 69 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• 11.2 CARDIOLOGY
  • 11.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET
  • TABLE 70 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 71 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 11.3 ORTHOPEDIC
  • 11.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH
  • TABLE 72 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 73 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 11.4 ONCOLOGY
  • 11.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
  • TABLE 74 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 75 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 11.5 NEUROLOGY
  • 11.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
  • TABLE 76 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 77 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 11.6 OBSTETRICS & GYNECOLOGY
  • 11.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS
  • TABLE 78 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 79 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 11.7 OTHER APPLICATIONS
  • TABLE 80 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 81 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER

• 12.1 INTRODUCTION
  • TABLE 82 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 83 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 12.2 HOSPITALS & CLINICS
  • 12.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
  • TABLE 84 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 85 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 12.3 DIAGNOSTIC CENTERS
  • 12.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS
  • TABLE 86 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 87 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 12.4 AMBULATORY SURGERY CENTERS
  • 12.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS
  • TABLE 88 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 89 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
• 12.5 OTHER END USERS
  • TABLE 90 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 91 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)

13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION

• 13.1 INTRODUCTION
  • TABLE 92 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018-2022 (USD MILLION)
  • TABLE 93 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023-2029 (USD MILLION)
• 13.2 NORTH AMERICA
  • FIGURE 31 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
  • TABLE 94 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 95 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 97 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 99 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 101 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 103 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 105 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 106 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 107 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 109 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 111 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.2.1 NORTH AMERICA: RECESSION IMPACT
  • 13.2.2 US
    • 13.2.2.1 Rising incidences of chronic diseases to drive market
  • TABLE 112 US: KEY MACRO INDICATORS
  • TABLE 113 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 114 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 115 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 116 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 117 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 118 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 119 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 120 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 121 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 122 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 123 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 124 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 125 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 126 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 127 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 128 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.2.3 CANADA
    • 13.2.3.1 Rising cases of end-stage kidney diseases to propel use of VNA and PACS solutions
  • TABLE 129 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 130 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 131 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 132 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 133 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 134 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 135 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 136 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 137 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 138 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 139 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 140 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 141 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 142 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 143 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 144 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3 EUROPE
  • 13.3.1 EUROPE: RECESSION IMPACT
  • TABLE 145 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 146 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • TABLE 147 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 148 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 149 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 150 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 151 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 152 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 153 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 154 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 155 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 156 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 157 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 158 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 159 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 160 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 161 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 162 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)

• 13.3.2 GERMANY
  • 13.3.2.1 High number of MRI units to drive market
• TABLE 163 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 164 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 165 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 166 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 167 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 168 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 169 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 170 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 171 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 172 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 173 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 174 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 175 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 176 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 177 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 178 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3.3 UK
  • 13.3.3.1 Increasing investments in diagnostic imaging to drive market
• FIGURE 32 COUNT OF DIAGNOSTIC IMAGING ACTIVITY IN UK, ON NHS PATIENTS, FROM JANUARY 2022 TO JANUARY 2023
• TABLE 179 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 180 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 181 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 182 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE 2023-2029 (USD MILLION)
• TABLE 183 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 184 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 185 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 186 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 187 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 188 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 189 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 190 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 191 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 192 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 193 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 194 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3.4 FRANCE
  • 13.3.4.1 Rising target patient population and government-funded investments for advanced medical equipment to fuel uptake
• TABLE 195 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 196 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 197 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 198 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 199 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 200 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
• TABLE 201 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 202 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 203 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 204 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 205 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 206 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 207 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 208 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 209 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 210 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3.5 ITALY
  • 13.3.5.1 Established healthcare infrastructure to support overall market growth
• TABLE 211 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 212 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 213 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 214 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 215 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 216 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 217 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 218 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 219 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 220 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 221 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 222 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 223 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 224 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 225 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 226 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3.6 SPAIN
  • 13.3.6.1 Growing access to advanced cancer diagnostics to propel market
• TABLE 227 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 228 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 229 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 230 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 231 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 232 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 233 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 234 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 235 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 236 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 237 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 238 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 239 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 240 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 241 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 242 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.3.7 REST OF EUROPE
• TABLE 243 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 244 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
• TABLE 245 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 246 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
• TABLE 247 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
• TABLE 248 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
• TABLE 249 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
• TABLE 250 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
• TABLE 251 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
• TABLE 252 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
• TABLE 253 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
• TABLE 254 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
• TABLE 255 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
• TABLE 256 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
• TABLE 257 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
• TABLE 258 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.4 ASIA PACIFIC
  • 13.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 33 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
  • TABLE 259 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 265 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 268 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 269 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 272 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 274 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 276 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.4.2 JAPAN
    • 13.4.2.1 Presence of universal healthcare coverage to fuel market
  • TABLE 277 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 278 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 279 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 280 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 281 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 282 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 283 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 284 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 285 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 286 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 287 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 288 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 289 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 290 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 291 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 292 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.4.3 CHINA
    • 13.4.3.1 Strong government support for healthcare reforms and increasing number of medical imaging procedures to drive market
  • TABLE 293 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 294 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 295 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 296 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 297 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 298 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 299 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 300 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 301 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 302 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 303 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 304 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 305 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 306 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 307 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 308 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.4.4 INDIA
    • 13.4.4.1 Improving healthcare infrastructure to support growth of medical image analysis software market
  • TABLE 309 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 310 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 311 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 312 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 313 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 314 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 315 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 316 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 317 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 318 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 319 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 320 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 321 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 322 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 323 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 324 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.4.5 REST OF ASIA PACIFIC
  • TABLE 325 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 326 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 327 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 328 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 329 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 330 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 331 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 334 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 335 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 336 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 337 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 338 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 339 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 340 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
• 13.5 LATIN AMERICA
  • 13.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 341 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018-2022 (USD MILLION)
  • TABLE 342 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023-2029 (USD MILLION)
  • TABLE 343 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 344 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 346 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 348 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 349 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 350 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 351 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 352 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 353 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 354 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 355 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 356 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 357 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 358 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.5.2 BRAZIL
    • 13.5.2.1 High export of medical devices to propel market
  • TABLE 359 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 360 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 361 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 362 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 363 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 364 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023-2029 (USD MILLION)
  • TABLE 365 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 366 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 367 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 368 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 369 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 370 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 371 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 372 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 373 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 374 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.5.3 MEXICO
    • 13.5.3.1 Rapid technological advancements in imaging solutions to support market growth
  • TABLE 375 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 376 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 377 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 378 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 379 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 380 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 381 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 382 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 383 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 384 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 385 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 386 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 387 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 388 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 389 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 390 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.5.4 REST OF LATIN AMERICA
  • TABLE 391 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 392 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 393 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 394 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 395 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 396 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 397 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 398 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 399 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 405 REST OF LATINA AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 406 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)

• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS
  • TABLE 407 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018-2022 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 409 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 410 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 411 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 412 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 413 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 414 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 416 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 417 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 418 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 419 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 420 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 421 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 422 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 423 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 424 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
  • TABLE 425 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 426 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 427 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 428 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 430 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 431 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 432 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 433 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 434 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 435 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 436 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 438 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 439 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 440 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 13.6.3 REST OF MIDDLE EAST & AFRICA
  • TABLE 441 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 442 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 443 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 444 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 445 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018-2022 (USD MILLION)
  • TABLE 446 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023-2029 (USD MILLION)
  • TABLE 447 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
  • TABLE 448 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
  • TABLE 449 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018-2022 (USD MILLION)
  • TABLE 450 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2029 (USD MILLION)
  • TABLE 451 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018-2022 (USD MILLION)
  • TABLE 452 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023-2029 (USD MILLION)
  • TABLE 453 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
  • TABLE 454 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023-2029 (USD MILLION)
  • TABLE 455 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018-2022 (USD MILLION)
  • TABLE 456 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023-2029 (USD MILLION)

14 COMPETITIVE LANDSCAPE

• 14.1 OVERVIEW
• 14.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
  • FIGURE 34 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
• 14.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS
• 14.4 MARKET SHARE ANALYSIS
  • FIGURE 36 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2022)
  • TABLE 457 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION
• 14.5 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 14.5.1 AGFA-GEVAERT GROUP
  • 14.5.2 FUJIFILM HOLDINGS CORPORATION
  • 14.5.3 MERATIVE
  • 14.5.4 NOVARAD CORPORATION
  • 14.5.5 PAXERAHEALTH
  • 14.5.6 ONEPACS
• 14.6 COMPANY EVALUATION AND FINANCIAL METRICS
  • FIGURE 37 EV/EBITDA OF KEY VENDORS
  • FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
• 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 14.7.1 STARS
  • 14.7.2 EMERGING LEADERS
  • 14.7.3 PERVASIVE PLAYERS
  • 14.7.4 PARTICIPANTS
  • FIGURE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 14.7.5 COMPANY FOOTPRINT ANALYSIS
  • TABLE 458 OVERALL COMPANY FOOTPRINT
  • TABLE 459 PRODUCT TYPE FOOTPRINT
  • TABLE 460 DEPLOYMENT FOOTPRINT
  • TABLE 461 END USER FOOTPRINT
  • TABLE 462 REGIONAL FOOTPRINT (19 COMPANIES)
• 14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 14.8.1 PROGRESSIVE COMPANIES
  • 14.8.2 RESPONSIVE COMPANIES
  • 14.8.3 DYNAMIC COMPANIES
  • 14.8.4 STARTING BLOCKS
  • FIGURE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • 14.8.5 COMPETITIVE BENCHMARKING
  • TABLE 463 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 464 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
• 14.9 COMPETITIVE SITUATIONS & TRENDS
  • 14.9.1 PRODUCT LAUNCHES & UPGRADES
  • TABLE 465 PRODUCT LAUNCHES & UPGRADES, AUGUST 2021-NOVEMBER 2023
  • 14.9.2 DEALS
  • TABLE 466 DEALS, JANUARY 2023-MARCH 2024
  • 14.9.3 OTHER DEVELOPMENTS
  • TABLE 467 OTHER DEVELOPMENTS, NOVEMBER 2022-NOVEMBER 2024

15 COMPANY PROFILES

• 15.1 KEY COMPANIES
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 15.1.1 AGFA-GEVAERT GROUP
• TABLE 468 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW
• FIGURE 41 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
• TABLE 469 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
• TABLE 470 AGFA-GEVAERT GROUP: DEALS, JANUARY 2020-APRIL 2024
• 15.1.2 FUJIFILM HOLDINGS CORPORATION
• TABLE 471 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
• FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
• TABLE 472 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
• TABLE 473 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020-APRIL 2024
• TABLE 474 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020-APRIL 2024
• 15.1.3 SECTRA AB
• TABLE 475 SECTRA AB: BUSINESS OVERVIEW
• FIGURE 43 SECTRA AB: COMPANY SNAPSHOT
• TABLE 476 SECTRA AB: SOLUTIONS OFFERED
• 15.1.4 GE HEALTHCARE TECHNOLOGIES INC.
• TABLE 477 GE HEALTHCARE TECHNOLOGIES INC.: BUSINESS OVERVIEW
• FIGURE 44 GE HEALTHCARE TECHNOLOGIES INC.: COMPANY SNAPSHOT
• TABLE 478 GE HEALTHCARE TECHNOLOGIES INC.: SOLUTIONS OFFERED
• TABLE 479 GE HEALTHCARE TECHNOLOGIES INC.: PRODUCTS LAUNCHES, JANUARY 2020-APRIL 2024
• 15.1.5 MERATIVE
• TABLE 480 MERATIVE: BUSINESS OVERVIEW
• TABLE 481 MERATIVE: SOLUTIONS OFFERED
• TABLE 482 MERATIVE: DEALS, NOVEMBER 2023
• 15.1.6 KONINKLIJKE PHILIPS N.V.
• TABLE 483 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
• FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
• TABLE 484 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
• TABLE 485 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2020-APRIL 2024
• TABLE 486 KONINKLIJKE PHILIPS N.V.: DEALS, APRIL 2023
• 15.1.7 CANON MEDICAL SYSTEMS CORPORATION
• TABLE 487 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
• FIGURE 46 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
• TABLE 488 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
• TABLE 489 CANON MEDICAL SYSTEMS CORPORATION: DEALS, NOVEMBER 203
• TABLE 490 CANON MEDICAL SYSTEMS CORPORATION: OTHER DEVELOPMENTS, NOVEMBER 2022
• 15.1.8 INTELERAD MEDICAL SYSTEMS INCORPORATED
• TABLE 491 INTELERAD MEDICAL SYSTEMS INCORPORATED: BUSINESS OVERVIEW
• TABLE 492 INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTIONS OFFERED
• TABLE 493 INTELERAD MEDICAL SYSTEMS INCORPORATED: DEALS, DECEMBER 2020-NOVEMBER 2023
• TABLE 494 INTELERAD MEDICAL SYSTEMS INCORPORATED: OTHER DEVELOPMENTS, JULY 2021-NOVEMBER 2022
• 15.1.9 PAXERAHEALTH
• TABLE 495 PAXERAHEALTH: BUSINESS OVERVIEW
• TABLE 496 PAXERAHEALTH: SOLUTIONS OFFERED
• 15.1.10 NOVARAD CORPORATION
• TABLE 497 NOVARAD CORPORATION: BUSINESS OVERVIEW
• TABLE 498 NOVARAD CORPORATION: SOLUTIONS OFFERED
• 15.1.11 HYLAND SOFTWARE, INC.
• TABLE 499 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW
• TABLE 500 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
• TABLE 501 HYLAND SOFTWARE, INC.: PRODUCTS LAUNCHES & UPGRADES, DECEMBER 2020
• TABLE 502 HYLAND SOFTWARE, INC.:DEALS, SEPTEMBER 2021-FEBRUARY 2024
• 15.1.12 SIEMENS HEALTHCARE LIMITED
• TABLE 503 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW
• FIGURE 47 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT
• TABLE 504 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED
• 15.1.13 BRIDGEHEAD SOFTWARE LTD.
• TABLE 505 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW
• TABLE 506 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
• TABLE 507 BRIDGEHEAD SOFTWARE LTD.: PRODUCTS LAUNCHES & UPGRADES, MAY 2020
• TABLE 508 BRIDGEHEAD SOFTWARE LTD.: DEALS, SEPTEMBER 2022
• 15.1.14 CANOPY PARTNERS
• TABLE 509 CANOPY PARTNERS: BUSINESS OVERVIEW
• TABLE 510 CANOPY PARTNERS: SOLUTIONS OFFERED
• 15.1.15 CRELIOHEALTH INC.
• TABLE 511 CRELIOHEALTH INC.: BUSINESS OVERVIEW
• TABLE 512 CRELIOHEALTH INC.: SOLUTIONS OFFERED
• 15.1.16 ASPYRA, LLC
• TABLE 513 ASPYRA, LLC: BUSINESS OVERVIEW
• TABLE 514 ASPYRA, LLC: SOLUTIONS OFFERED
• 15.1.17 POSTDICOM
• TABLE 515 POSTDICOM: BUSINESS OVERVIEW
• TABLE 516 POSTDICOM: SOLUTIONS OFFERED
• 15.1.18 MEDICASOFT
• TABLE 517 MEDICASOFT: BUSINESS OVERVIEW
• TABLE 518 MEDICASOFT: SOLUTIONS OFFERED
• 15.1.19 ESAOTE SPA
• TABLE 519 ESAOTE SPA.: BUSINESS OVERVIEW
• TABLE 520 ESAOTE SPA.: SOLUTIONS OFFERED
• 15.1.20 VISUS HEALTH IT GMBH
• TABLE 521 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW
• TABLE 522 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
• 15.2 OTHER PLAYERS
  • 15.2.1 ADVAHEALTH SOLUTIONS
  • 15.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
  • 15.2.3 ARO SYSTEMS
  • 15.2.4 CENTRAL DATA NETWORKS
  • 15.2.5 ONEPACS
  • 15.2.6 DEDALUS S.P.A.

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS